| FORM 3 | UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934 or Section 30(h) of the Investment Company Act of 1940 |
| |||||||||||||||
1. Name and Address of Reporting Person*
(Street)
(Country) | 2. Date of Event Requiring Statement
(Month/Day/Year) 03/18/2026 | 3. Issuer Name and Ticker or Trading Symbol
Klarna Group plc [ KLAR ] | |||||||||||||||
| 3a. Foreign Trading Symbol
| 5. If Amendment, Date of Original Filed
(Month/Day/Year) | ||||||||||||||||
| 4. Relationship of Reporting Person(s) to Issuer
(Check all applicable)
| 6. Individual or Joint/Group Filing (Check Applicable Line)
| ||||||||||||||||
| Table I - Non-Derivative Securities Beneficially Owned | |||
|---|---|---|---|
| 1. Title of Security (Instr. 4) | 2. Amount of Securities Beneficially Owned (Instr. 4) | 3. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 4. Nature of Indirect Beneficial Ownership (Instr. 5) |
| Klarna Group plc Ordinary Shares | 1,023(1) | D | |
| Table II - Derivative Securities Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities) | |||||||
|---|---|---|---|---|---|---|---|
| 1. Title of Derivative Security (Instr. 4) | 2. Date Exercisable and Expiration Date (Month/Day/Year) | 3. Title and Amount of Securities Underlying Derivative Security (Instr. 4) | 4. Conversion or Exercise Price of Derivative Security | 5. Ownership Form: Direct (D) or Indirect (I) (Instr. 5) | 6. Nature of Indirect Beneficial Ownership (Instr. 5) | ||
| Date Exercisable | Expiration Date | Title | Amount or Number of Shares | ||||
| Larkan AB Restricted Stock Units | (2) | (2) | Klarna Group plc ordinary shares | (2) | (2) | D | |
| Larkan SPV Warrants L4:1 | 09/01/2027 | 11/15/2027 | Klarna Group plc ordinary shares | 833,676(3) | $6,885.33(8) | D | |
| Larkan SPV Warrants L5:2 | 09/01/2027 | 11/15/2027 | Klarna Group plc ordinary shares | 879,492(4) | $6,885.33(8) | D | |
| Larkan SPV Warrants L10:1 | 09/01/2028 | 11/30/2028 | Klarna Group plc ordinary shares | 23,196(5) | $2,295.11(8) | D | |
| Larkan SPV Warrants L10:2 | 09/01/2028 | 11/30/2028 | Klarna Group plc ordinary shares | 125,088(6) | $6,885.33(8) | D | |
| Klarna Group plc Options | 12/31/2024 | 06/29/2029 | Klarna Group plc ordinary shares | 252,024 | $374.25(8) | D | |
| Klarna Group plc Options | 03/05/2026 | 09/05/2029 | Klarna Group plc ordinary shares | 250,908 | $374.25(8) | D | |
| Klarna Group plc Options | 03/05/2026 | 09/05/2029 | Klarna Group plc ordinary shares | 452,760(7) | $748.5(8) | D | |
| Klarna Group plc Options | 03/05/2026 | 09/05/2029 | Klarna Group plc ordinary shares | 1,006,476(7) | $1,122.75(8) | D | |
| Explanation of Responses: |
| 1. In addition to the ordinary shares reported in this Form 3, the reporting person beneficially owns a number of the Klarna Group plcs (the Issuer) Class B shares. Each Class B share is entitled to 10 votes per share. Class B shares are not transferable and are not exchangeable for or convertible into ordinary shares. |
| 2. Represents 4,132 restricted stock units in Larkan AB (Larkan), an indirect subsidiary of Klarna Group plc (the Issuer). Once shares of Larkan are delivered in settlement of the restricted stock units, approximately four shares of Larkan are convertible into one Klarna Group plc ordinary share (Shares). Restricted Stock Units in Larkan vest quarterly, at a total vesting of 25% of the initial grant per year. |
| 3. Represents warrants to acquire 69,473 shares of Larkan IV AB, a direct subsidiary of the Issuer. Each underlying share of Larkan IV AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 833,676 Shares being subject to the warrant, that is vesting annually by 20% for a period of four years with an additional 20% vesting on August 27, 2027. |
| 4. Represents warrants to acquire 73,291 shares of Larkan V AB, a direct subsidiary of the Issuer. Each underlying share of Larkan V AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 879,492 Shares being subject to the warrant, that is vesting annually by 20% for a period of four years with an additional 20% vesting on August 27, 2027. |
| 5. Represents warrants to acquire 1,933 shares of Larkan X AB, a direct subsidiary of the Issuer. Each underlying share of Larkan X AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 23,196 Shares being subject to the warrant, that is vesting annually in equal installments. |
| 6. Represents warrants to acquire 10,424 shares of Larkan X AB, a direct subsidiary of the Issuer. Each underlying share of Larkan X AB is convertible into approximately twelve Shares based on a formula set forth in the applicable award agreement, resulting in 125,088 Shares being subject to the warrant, that is vesting annually in equal instalments. |
| 7. Represents an option to acquire Shares that vest in four equal annual instalments beginning on the first anniversary of the grant date. |
| 8. This is in SEK. |
| Boudien Moerman, as attorney-in-fact | 03/18/2026 | |
| ** Signature of Reporting Person | Date | |
| Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly. | ||
| * If the form is filed by more than one reporting person, see Instruction 5 (b)(v). | ||
| ** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a). | ||
| Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure. | ||
| Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number. | ||
| * Form 3: SEC 1473 (03-26) | ||